CCR5 or CXCR4 is required for efficient infection of peripheral blood mononuclear cells by promiscuous human immunodeficiency virus type 2 primary isolates

AIDS Research and Human Retroviruses

Volumn 18, Issue 3, 2002, Pages 193-200

  Mörner, Andreas ^a   Björndal, Åsa ^a   Leandersson, Ann Charlotte ^a   Albert, Jan ^a   Björling, Ewa ^a   Jansson, Marianne ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE RECEPTOR;

ARTICLE; CONTROLLED STUDY; GENOTYPE; HOST CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MONONUCLEAR CELL; PRIORITY JOURNAL; TISSUE CULTURE; VIRUS ISOLATION; VIRUS REPLICATION;

CELLS, CULTURED; HIV-1; HIV-2; HUMANS; LEUKOCYTES, MONONUCLEAR; RECEPTORS, CCR5; RECEPTORS, CXCR4; VIRUS REPLICATION;

EID: 0036178171     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/08892220252781248     Document Type: Article

References (32)

1. HIV entry and tropism: The chemokine receptor connection
2. Unwelcomed guests with master keys: How HIV uses chemokine receptors for cellular entry
3. Co-receptors for HIV-1 entry
4. A new classification for HIV-1
5. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection
6. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene
7. The influence of MT-2 tropism on the prognostic implications of the delta32 deletion in the CCR-5 gene
8. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia growth and development study, multicenter AIDS cohort study, multicenter hemophilia cohort study, San Francisco City cohort, ALIVE study
9. Heterozygosity for a deletion in the CKR-5 gene leads to prolonged AIDS-free survival and slower CD4 T-cell decline in a cohort of HIV-seropositive individuals
10. Coreceptor use by primate lentiviruses
11. Replicative capacity of HIV-2, like HIV-1, correlates with severity of immunodeficiency
12. Genetically divergent strains of human immunodeficiency virus type 2 use multiple coreceptors for viral entry
13. Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage
14. Slower heterosexual spread of HIV-2 than HIV-1
15. Reduced rate of disease development after HIV-2 infection as compared to HIV-1
16. Autologous neutralizing antibodies prevail in HIV-2 but not in HIV-1 infection
17. A capture enzyme immunoassay for detection of HIV-2/SIV antigen
18. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes
19. Expression patterns of the HIV type 1 coreceptors CCR5 and CXCR4 on CD4+ T cells and monocytes from cord and adult blood
20. The chemokine system: Redundancy for robust outputs
21. Expression and coreceptor activity of STRL33/Bonzo on primary peripheral blood lymphocytes
22. Role of CCR5 in infection of primary macrophages and lymphocytes by macrophage-tropic strains of human immunodeficiency virus: Resistance to patient-derived and prototype isolates resulting from the delta ccr5 mutation
23. Coreceptor usage and RANTES sensitivity of non-syncytium-inducing HIV-1 isolates obtained from patients with AIDS
24. Use of inhibitors to evaluate coreceptor usage by simian and simian/human immunodeficiency viruses and human immunodeficiency virus type 2 in primary cells
25. Will multiple coreceptors need to be targeted by inhibitors of human immunodeficiency virus type 1 entry?
26. CXCR4 as a functional coreceptor for human immunodeficiency virus type 1 infection of primary macrophages
27. Exclusive and persistent use of the entry coreceptor CXCR4 by human immunodeficiency virus type 1 from a subject homozygous for CCR5 delta32
28. Viral entry through CXCR4 is a pathogenic factor and therapeutic target in human immunodeficiency virus type 1 disease
29. Cytopathicity of human immunodeficiency virus type 2 (HIV-2) in human lymphoid tissue is coreceptor dependent and comparable to that of HIV-1
30. Co-receptor usage of BOB/GPR15 in addition to CCR5 has no significant effect on replication of simian immunodeficiency virus in vivo
31. Adaptation to promiscuous usage of chemokine receptors is not a prerequisite for human immunodeficiency virus type 1 disease progression
32. Natural infection of a homozygous delta24 CCR5 red-capped mangabey with an R2b-tropic simian immunodeficiency virus